# Investigating the Utilisation and Effectiveness of Originator and Biosimilar Anti-TNF Agents

> **NCT03470688** · — · UNKNOWN · sponsor: **Opal Rheumatology Ltd.** · enrollment: 5000 (estimated)

## Conditions studied

- Rheumatoid Arthritis
- Psoriatic Arthritis
- Ankylosing Spondylitis

## Interventions

- **BIOLOGICAL:** Originator
- **BIOLOGICAL:** Biosimilar

## Key facts

- **NCT ID:** NCT03470688
- **Lead sponsor:** Opal Rheumatology Ltd.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-03-01
- **Primary completion:** 2021-06-01
- **Final completion:** 2021-12-31
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2018-03-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03470688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03470688, "Investigating the Utilisation and Effectiveness of Originator and Biosimilar Anti-TNF Agents". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03470688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*